Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("AMPHOTERICINE B")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 2875

  • Page / 115
Export

Selection :

  • and

STABILITY STUDIES WITH AMPHOTERICIN B AND AMPHOTERICIN B METHYL ESTERBONNER DP; MECHLINSKI W; SCHAFFNER CP et al.1975; J. ANTIBIOT.; JAP.; DA. 1975; VOL. 28; NO 2; PP. 132-135; BIBL. 10REF.Article

REDUCED TOXICITY OF AMPHOTERICIN B METHYL ESTER (AME)VS. AMPHOTERICIN B AND FUNGIZONE IN TISSUE CULTURE = REDUCTION DE LA TOXICITE DE L'ESTER METHYLIQUE D'AMPHOTERICINE B(EMA) PAR RAPPORT A L'AMPHOTERICINE B ET LA FUNGIZONE EN CULTURE DE TISSUFISHER PB; GOLDSTEIN NI; BRYSON V et al.1976; IN VITRO; U.S.A.; DA. 1976; VOL. 12; NO 2; PP. 133-140; BIBL. 1 P. 1/2Article

COMPARATIVE IN VITRO ANTIFUNGAL ACTIVITY OF AMPHOTERICINB AND AMPHOTERICIN B METHYL ESTERHOWARTH WR; TEWARI RP; SOLOTOROVSKY M et al.1975; ANTIMICROB. AGENTS CHEMOTHERAPY; U.S.A.; DA. 1975; VOL. 7; NO 1; PP. 58-63; BIBL. 11REF.Article

A BIOLOGICALLY ACTIVE BORATE DERIVATIVE OF AMPHOTERICIN B SOLUBLE IN SALINE SOLUTION.KRAL F; STRAUSS G.1978; J. ANTIBIOT.; JAP.; DA. 1978; VOL. 31; NO 2; PP. 257-259; BIBL. 6 REF.Article

COMPARATIVE CHEMOTHERAPEUTIC ACTIVITY OF AMPHOTERICIN B AND AMPHOTERICIN B METHYL ESTERBONNER DP; TEWARI RP; SOLOTOROVSKY M et al.1975; ANTIMICROB. AGENTS CHEMOTHERAPY; U.S.A.; DA. 1975; VOL. 7; NO 6; PP. 724-729; BIBL. 14REF.Article

A labile point in mutant amphotericin polyketide synthasesKHAN, Naseem; RAWLINGS, Bernard; CAFFREY, Patrick et al.Biotechnology letters. 2011, Vol 33, Num 6, pp 1121-1126, issn 0141-5492, 6 p.Article

Amphotericin BLEMKE, A; KIDERLEN, A. F; KAYSER, O et al.Applied microbiology and biotechnology. 2005, Vol 68, Num 2, pp 151-162, issn 0175-7598, 12 p.Article

Lipid formulations of amphotericin B as first-line treatment of zygomycosisPETRIKKOS, G. L.Clinical microbiology and infection. Supplement. 2009, Vol 15, Num 5, pp 87-92, issn 1470-9465, 6 p.Conference Paper

COMPARATINE SENSITIVITY OF NAEGLERIA FOMLERI TO AMPHOTERICIN B AND AMPHOTERICIN B METHY ESTERFERRANTE A.1982; TRANS. R. TROP. MED. HYG.; ISSN 0035-9203; GBR; DA. 1982; VOL. 76; NO 4; PP. 476-478; BIBL. 16 REF.Article

N-AMINOACYL DERIVATIVES OF POLYENE MACROLIDE ANTIBIOTICS AND THEIR ESTERSWRIGHT JJK; ALBARELLA JA; KREPSKI LR et al.1982; JOURNAL OF ANTIBIOTICS; ISSN 0021-8820; JPN; DA. 1982; VOL. 35; NO 7; PP. 911-914; BIBL. 16 REF.Article

COMPARATIVE IN VITRO SUSCEPTIBILITY OF YEASTS TO AMPHOTERICIN B AND THREE METHYL ESTER DERIVATIVESOBLACK DL; HEWITT WL; MARTIN WJ et al.1981; ANTIMICROB. AGENTS CHEMOTHER.; ISSN 0066-4804; USA; DA. 1981; VOL. 19; NO 1; PP. 106-109; BIBL. 13 REF.Article

ANTIOXIDANT-MEDIATED INCREASES IN THE ANTIFUNGAL ACTIVITIES OF AMPHOTERICIN B AND ITS METHYL ESTER DERIVATIVEBEGGS WH; ANDREWS FA.1980; RES. COMMUN. CHEM. PATHOL. PHARMACOL.; ISSN 0034-5164; USA; DA. 1980; VOL. 29; NO 2; PP. 389-392Article

INCREASED AMPHOTERICIN B METHYL ESTER ACTIVITY IN THE PRESENCE OF ANTIOXIDANTSBEGGS WH; ANDREWS FA; SAROSI GA et al.1980; J. ANTIMICROB. CHEMOTHERAPY; GBR; DA. 1980; VOL. 6; NO 2; PP. 291-292; BIBL. 7 REF.Article

Large-conductance cholesterol-amphotericin B channels in reconstituted lipid bilayersYILMA, Solomon; CANNON-SYKORA, Jennifer; SAMOYLOV, Alexandre et al.Biosensors & bioelectronics. 2007, Vol 22, Num 7, pp 1359-1367, issn 0956-5663, 9 p.Article

Acute amphotericin B overdoseBURKE, Douglas; LAL, Rajiv; FINKEL, Kevin W et al.The Annals of pharmacotherapy. 2006, Vol 40, Num 12, pp 2254-2259, issn 1060-0280, 6 p.Article

Peptide stabilized amphotericin B nanodisksTUFTELAND, Megan; PESAVENTO, Joseph B; BERMINGHAM, Rachelle L et al.Peptides (New York, NY. 1980). 2007, Vol 28, Num 4, pp 741-746, issn 0196-9781, 6 p.Article

Liposomal amphotericin B. Author's repliesRINGDEN, O; TOLLEMAR, J; TYDEN, G et al.Lancet (British edition). 1992, Vol 339, Num 8789, pp 374-375, issn 0140-6736Article

Antifungals and renal safety- : getting the balance rightSALIBA, Faouzi.International journal of antimicrobial agents. 2006, Vol 27, issn 0924-8579, S21-S24, SUP1Article

Interactions between amphotericin B 3-(N',N'-dimethylamino) propyl amide and cellular membrane components in Langmuir monolayersHAC-WYDRO, Katarzyna; DYNAROWICZ-LATKA, Patrycja; GRZYBOWSKA, Jolanta et al.Thin solid films. 2008, Vol 516, Num 6, pp 1197-1203, issn 0040-6090, 7 p.Article

Current Options in Antifungal PharmacotherapyMOHR, John; JOHNSON, Melissa; COOPER, Travis et al.Pharmacotherapy. 2008, Vol 28, Num 5, pp 614-645, issn 0277-0008, 32 p.Article

TRANSFER OF THE POLYENE ANTIBIOTIC AMPHOTERICIN B BETWEEN SINGLE-WALLED VESICLES OF DIPALMITOYLPHOSPHATIDYLCHOLINE AND EGG-YOLK PHOSPHATIDYLCHOLINEBOLARD J; VERTUT CROQUIN A; CYBULSKA BE et al.1981; BIOCHIM. BIOPHYS. ACTA; ISSN 0006-3002; NLD; DA. 1981; VOL. 647; NO 2; PP. 241-248; BIBL. 16 REF.Article

TREATMENT OF KERATOMYCOSIS WITH AMPHOTERICIN B 0,15%WOOD TO; WILLIFORD W.1976; AMER. J. OPHTHALMOL.; U.S.A.; DA. 1976; VOL. 81; NO 6; PP. 847-849; BIBL. 6 REF.Article

RECOVERY FROM DISSEMINATED CANDIDIASIS IN A PREMATURE NEONATEHILL HR; MITCHELL TG; MATSEN JM et al.1974; PEDIATRICS; U.S.A.; DA. 1974; VOL. 53; NO 5 PART. 1; PP. 748-752; BIBL. 19REF.Article

MODIFICATIONS ECG ET MORPHOLOGIQUES DANS LE MYOCARDE DES ANIMAUX LORS DE L'INJECTION INTRAVEINEUSE D'AMPHOTERICINE BDUMOVA AM; SPASSKAYA MG.1973; ANTIBIOTIKI; S.S.S.R.; DA. 1973; VOL. 18; NO 7; PP. 650-655; ABS. ANGL.; BIBL. 15REF.Serial Issue

COMBINED ASSAY AND DETERMINATION OF BIOACTIVITY OF POLYENE ANTIBIOTICS BY FLOW NEPHELOMETRYBEEZER AE; CHOWDHRY BZ.1981; TALANTA (OXF.); ISSN 0039-9140; GBR; DA. 1981; VOL. 28; NO 9; PP. 647-652; BIBL. 22 REF.Article

  • Page / 115